| GlaxoSmithKline is a British drug company that | | | | most common type of cancer in women. There |
| also makes a drug called Cervarix. It is used for | | | | are several types of HPV and among them, |
| treating cervical cancer. Cervarix is actually a | | | | nearly 15 of kinds are known to cause cancer. |
| vaccine that helps to prevent cervical cancer in | | | | Cervarix effectiveness against these viruses is still |
| women. This particular drug has been in the | | | | to be established. Also, it has not been proven as |
| market since 2006 and its only competitor is | | | | yet whether Cervarix fights the cancer strain. In |
| Gardasil. Cervarix has been approved in nearly 100 | | | | addition, research that supports the effectiveness |
| countries now. However, the release of this drug | | | | of the drug is completely nil because there is no |
| was been delayed in the United States since the | | | | confirmed proof that women who have taken the |
| year 2007. One of the main reasons was for the | | | | vaccine have prevented onset of cervical cancer. |
| lack of evidence of its effectiveness. Also, the | | | | Another concern is the pricing for the vaccine and |
| Food and Drug Administration of the United | | | | Glaxo has not clearly indicated or discussed the |
| States has requested the concerned officials of | | | | pricing in the markets. The success of the vaccine |
| the company to provide more information on the | | | | completely depends on these factors. |
| creditability of the drug. | | | | However, now the FDA has approved the |
| Apparently one in every four women in the | | | | vaccine, and many hope that the vaccine will be |
| United States suffers from cervical cancer. It is a | | | | able to help many women who would otherwise |
| very high number compared to the general | | | | contract cervical cancer. |
| population. Cervical cancer happens to be the | | | | |